2012
DOI: 10.1038/nbt.2107
|View full text |Cite
|
Sign up to set email alerts
|

Generation of human vascular smooth muscle subtypes provides insight into embryological origin–dependent disease susceptibility

Abstract: Heterogeneity of embryological origins is a hallmark of vascular smooth muscle cells (SMCs), which may influence vascular disease development. Differentiation of human pluripotent stem cells (hPSCs) into developmental origin-specific SMC subtypes remains elusive. In this study, we have established a chemically defined protocol where hPSCs were initially induced to form neuroectoderm, lateral plate mesoderm or paraxial mesoderm. These intermediate populations were further differentiated towards SMCs (>80% MYH11… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

13
408
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 341 publications
(422 citation statements)
references
References 51 publications
(51 reference statements)
13
408
0
1
Order By: Relevance
“…The purification/isolation of highly pure brown adipocytes should be facilitated by the ability to engineer stem cell lines in which key markers of the BAT lineage are marked with fluorescent, antibiotic or neutral cell-surface reporters. The combination of genetic lineage marking using site-specific recombinases like Cre and highly defined human stem cell differentiation systems that mimic the progression of paraxial mesoderm formation during embryonic development (Francetic & Li 2011, Cheung et al 2012, Sakurai et al 2012) may help to resolve some of the outstanding controversial questions regarding the origin of both human classical BAT and brite cells and test the importance of various factors in directing BAT/brite cell fate. Engineered reporter lines could also be employed in largescale chemical screening for compounds that influence BAT formation/activity and are potential therapeutic drugs for metabolic disease.…”
Section: Future Opportunitiesmentioning
confidence: 99%
“…The purification/isolation of highly pure brown adipocytes should be facilitated by the ability to engineer stem cell lines in which key markers of the BAT lineage are marked with fluorescent, antibiotic or neutral cell-surface reporters. The combination of genetic lineage marking using site-specific recombinases like Cre and highly defined human stem cell differentiation systems that mimic the progression of paraxial mesoderm formation during embryonic development (Francetic & Li 2011, Cheung et al 2012, Sakurai et al 2012) may help to resolve some of the outstanding controversial questions regarding the origin of both human classical BAT and brite cells and test the importance of various factors in directing BAT/brite cell fate. Engineered reporter lines could also be employed in largescale chemical screening for compounds that influence BAT formation/activity and are potential therapeutic drugs for metabolic disease.…”
Section: Future Opportunitiesmentioning
confidence: 99%
“…During development, the formation of blood vessels is dependent upon the ability of endothelial cells to recruit precursor smooth muscle cells and promote their differentiation [9,10]. The recruitment and differentiation of vascular smooth muscle cells by endothelial cells is regulated by platelet-derived growth factor (PDGF), transforming growth factor-b (TGFb), and Notch signaling [11]; all factors which have been implicated in regulating mesenchymal stem cell differentiation [12][13][14]. Thus, the presence of endothelial cells within the mesenchymal stem cell environment likely plays a substantial role in their differentiation decisions.…”
mentioning
confidence: 99%
“…In addition to neuronal lineage differentiation, significant progresses have also been made in the differentiation of iPSCs towards many other cell types including cardiovascular fate, especially into cardiomyocytes, smooth muscle cells, and endothelial cells (Kattman et al, 2011;Cheung et al, 2012;Lian et al, 2012;Minami et al, 2012;Cao et al, 2013). These cells will be valuable applications in vascular diseases such as congenital vascular malformation, with abnormal blood vessels occur at birth.…”
Section: Disease Modelingmentioning
confidence: 99%